333 related articles for article (PubMed ID: 23729437)
1. Leishmania-infected MHC class IIhigh dendritic cells polarize CD4+ T cells toward a nonprotective T-bet+ IFN-γ+ IL-10+ phenotype.
Resende M; Moreira D; Augusto J; Cunha J; Neves B; Cruz MT; Estaquier J; Cordeiro-da-Silva A; Silvestre R
J Immunol; 2013 Jul; 191(1):262-73. PubMed ID: 23729437
[TBL] [Abstract][Full Text] [Related]
2. Induction of protective cellular immune responses against experimental visceral leishmaniasis mediated by dendritic cells pulsed with the N-terminal domain of Leishmania infantum elongation factor-2 and CpG oligodeoxynucleotides.
Agallou M; Pantazi E; Tsiftsaki E; Toubanaki DK; Gaitanaki C; Smirlis D; Karagouni E
Mol Immunol; 2018 Nov; 103():7-20. PubMed ID: 30173073
[TBL] [Abstract][Full Text] [Related]
3. Principal role of IL-12p40 in the decreased Th1 and Th17 responses driven by dendritic cells of mice lacking IL-12 and IL-18.
Lim HX; Hong HJ; Jung MY; Cho D; Kim TS
Cytokine; 2013 Aug; 63(2):179-86. PubMed ID: 23697689
[TBL] [Abstract][Full Text] [Related]
4. Polarization of naive T cells into Th1 or Th2 by distinct cytokine-driven murine dendritic cell populations: implications for immunotherapy.
Feili-Hariri M; Falkner DH; Morel PA
J Leukoc Biol; 2005 Sep; 78(3):656-64. PubMed ID: 15961574
[TBL] [Abstract][Full Text] [Related]
5. Cellular vaccination with bone marrow-derived dendritic cells pulsed with a peptide of Leishmania infantum KMP-11 and CpG oligonucleotides induces protection in a murine model of visceral leishmaniasis.
Agallou M; Margaroni M; Karagouni E
Vaccine; 2011 Jul; 29(31):5053-64. PubMed ID: 21569815
[TBL] [Abstract][Full Text] [Related]
6. Isolation of protective T cells from BALB/cJ mice chronically infected with Leishmania donovani.
Holaday B; Sadick MD; Pearson RD
J Immunol; 1988 Sep; 141(6):2132-7. PubMed ID: 3262649
[TBL] [Abstract][Full Text] [Related]
7. Splenic dendritic cells pulsed with Ixodes ricinus tick saliva prime naive CD4+T to induce Th2 cell differentiation in vitro and in vivo.
Mejri N; Brossard M
Int Immunol; 2007 Apr; 19(4):535-43. PubMed ID: 17344202
[TBL] [Abstract][Full Text] [Related]
8. Strategies for antigen choice and priming of dendritic cells influence the polarization and efficacy of antitumor T-cell responses in dendritic cell-based cancer vaccination.
Galea-Lauri J; Wells JW; Darling D; Harrison P; Farzaneh F
Cancer Immunol Immunother; 2004 Nov; 53(11):963-77. PubMed ID: 15146294
[TBL] [Abstract][Full Text] [Related]
9. Vaccination with Leishmania histone H1-pulsed dendritic cells confers protection in murine visceral leishmaniasis.
Agallou M; Smirlis D; Soteriadou KP; Karagouni E
Vaccine; 2012 Jul; 30(34):5086-93. PubMed ID: 22704924
[TBL] [Abstract][Full Text] [Related]
10. Complement C5a anaphylatoxin is an innate determinant of dendritic cell-induced Th1 immunity to Mycobacterium bovis BCG infection in mice.
Moulton RA; Mashruwala MA; Smith AK; Lindsey DR; Wetsel RA; Haviland DL; Hunter RL; Jagannath C
J Leukoc Biol; 2007 Oct; 82(4):956-67. PubMed ID: 17675563
[TBL] [Abstract][Full Text] [Related]
11. Interleukin 17A acts synergistically with interferon γ to promote protection against Leishmania infantum infection.
Nascimento MS; Carregaro V; Lima-Júnior DS; Costa DL; Ryffel B; Duthie MS; de Jesus A; de Almeida RP; da Silva JS
J Infect Dis; 2015 Mar; 211(6):1015-26. PubMed ID: 25274569
[TBL] [Abstract][Full Text] [Related]
12. The capacity to produce IFN-gamma rather than the presence of interleukin-4 determines the resistance and the degree of susceptibility to Leishmania donovani infection in mice.
Lehmann J; Enssle KH; Lehmann I; Emmendörfer A; Lohmann-Matthes ML
J Interferon Cytokine Res; 2000 Jan; 20(1):63-77. PubMed ID: 10670653
[TBL] [Abstract][Full Text] [Related]
13. NK cell activation in visceral leishmaniasis requires TLR9, myeloid DCs, and IL-12, but is independent of plasmacytoid DCs.
Schleicher U; Liese J; Knippertz I; Kurzmann C; Hesse A; Heit A; Fischer JA; Weiss S; Kalinke U; Kunz S; Bogdan C
J Exp Med; 2007 Apr; 204(4):893-906. PubMed ID: 17389237
[TBL] [Abstract][Full Text] [Related]
14. Human dendritic cells stimulated via TLR7 and/or TLR8 induce the sequential production of Il-10, IFN-gamma, and IL-17A by naive CD4+ T cells.
Lombardi V; Van Overtvelt L; Horiot S; Moingeon P
J Immunol; 2009 Mar; 182(6):3372-9. PubMed ID: 19265114
[TBL] [Abstract][Full Text] [Related]
15. Immunization with Leishmania infantum released proteins confers partial protection against parasite infection with a predominant Th1 specific immune response.
Rosa R; Marques C; Rodrigues OR; Santos-Gomes GM
Vaccine; 2007 Jun; 25(23):4525-32. PubMed ID: 17478016
[TBL] [Abstract][Full Text] [Related]
16. Dendritic cells generated in the presence of interferon-alpha stimulate allogeneic CD4+ T-cell proliferation: modulation by autocrine IL-10, enhanced T-cell apoptosis and T regulatory type 1 cells.
Carbonneil C; Saidi H; Donkova-Petrini V; Weiss L
Int Immunol; 2004 Jul; 16(7):1037-52. PubMed ID: 15184347
[TBL] [Abstract][Full Text] [Related]
17. T-bet inhibits the in vivo differentiation of parasite-specific CD4+ Th17 cells in a T cell-intrinsic manner.
Guo S; Cobb D; Smeltz RB
J Immunol; 2009 May; 182(10):6179-86. PubMed ID: 19414771
[TBL] [Abstract][Full Text] [Related]
18. Human dendritic cell (DC)-based anti-infective therapy: engineering DCs to secrete functional IFN-gamma and IL-12.
Ahuja SS; Mummidi S; Malech HL; Ahuja SK
J Immunol; 1998 Jul; 161(2):868-76. PubMed ID: 9670965
[TBL] [Abstract][Full Text] [Related]
19. Dendritic cell (DC)-based anti-infective strategies: DCs engineered to secrete IL-12 are a potent vaccine in a murine model of an intracellular infection.
Ahuja SS; Reddick RL; Sato N; Montalbo E; Kostecki V; Zhao W; Dolan MJ; Melby PC; Ahuja SK
J Immunol; 1999 Oct; 163(7):3890-7. PubMed ID: 10490989
[TBL] [Abstract][Full Text] [Related]
20. Leishmania infantum-specific T cell lines derived from asymptomatic dogs that lyse infected macrophages in a major histocompatibility complex-restricted manner.
Pinelli E; Gonzalo RM; Boog CJ; Rutten VP; Gebhard D; del Real G; Ruitenberg EJ
Eur J Immunol; 1995 Jun; 25(6):1594-600. PubMed ID: 7614987
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
